The mortality of septic shock remains high [Ann Intensive Care. 2017;7:19], so apart from usual therapy based on source control and antibiotics, some patients may need rescue therapies. Blood purification systems may play a role by facilitating the nonspecific removal of inflammatory mediators and microbiological toxins. There are different hemoadsorption systems, we describe in this case report the sequential use of Polymyxin B (PMX) endotoxin-adsorbing column (Toraymixin PMX-20R; Toray, Tokyo, Japan) and Cytosorb® (Cytosorbents Corp., New Jersey, USA).

1.
Yébenes
JC
,
Ruiz-Rodríguez
JC
,
Ferrer
R
,
Clèries
M
,
Bosch
A
,
Lorencio
C
,
Epidemiology of sepsis in catalonia: analysis of incidence and outcomes for patients in an European setting
.
Ann Intensive Care
.
2017
;
7
(
1
):
19
.
2.
Bonavia
A
,
Groff
A
,
Karamchandani
K
,
Singbartl
K
.
Clinical utility of extracorporeal cytokine hemoadsorption therapy: a literature review
.
Blood Purif
.
2018
;
46
:
337
49
. .
3.
Vincent
JL
,
Moreno
R
,
Takla
J
,
Willats
S
,
De Mendonça
A
,
Bruining
H
,
The SOFA (sepsisrelated organ failure assessment) score to describe organ dysfunction/failure
.
Intensive Care Med
.
1996
;
22
(
7
):
707
10
.
4.
Rhodes
A
,
Evans
LE
,
Alhazzani
W
,
Levy
MM
,
Antonelli
M
,
Ferrer
R
,
Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016
.
Intensive Care Med
.
2017
;
43
(
3
):
304
77
. .
5.
Khwaja
A
.
KDIGO clinical practice guidelines for acute kidney injury
.
Nephron Clin Pract
.
2012
;
120
(
4
):
c179
84
. .
6.
Opal
SM
,
Scannon
PJ
,
Vincent
JL
,
White
M
,
Carroll
SF
,
Palardy
JE
,
Relationship between plasma levels of lipopolysaccharide (LPS) and LPS-binding protein in patients with severe sepsis and septic shock
.
J Infect Dis
.
1999
;
180
:
1584
9
. .
7.
Chousterman
BG
,
Swirski
FK
,
Weber
GF
.
Cytokine storm and sepsis disease pathogenesis
.
Semin Immunopathol
.
2017
;
39
(
5
):
517
28
. .
8.
Jekarl
DW
,
Lee
SY
,
Lee
J
,
Park
YJ
,
Kim
Y
,
Park
JH
,
Procalcitonin as a diagnostic marker and IL-6 as a prognostic marker for sepsis
.
Diagn Microbiol Infect Dis
.
2013
;
75
(
4
):
342
7
. .
9.
CytoSorbents Corporation and CytoSorbents Medical Inc. CytoSorb_: a first-in-class cytokine filter approved in the European Union. Available from: http://www.cytosorbents.com/tech.html.
10.
Dellinger
RP
,
Bagshaw
SM
,
Antonelli
M
,
Foster
DM
,
Klein
DJ
,
Marshall
JC
,
Effect of targeted polymyxin B hemoperfusion on 28-day mortality in patients with septic shock and elevated endotoxin level: the EUPHRATES randomized clinical trial
.
JAMA
.
2018
;
320
:
1455
63
. .
11.
Klein
DJ
,
Foster
D
,
Walker
PM
,
Bagshaw
SM
,
Mekonnen
H
,
Antonelli
M
.
Polymyxin B hemoperfusion in endotoxemic septic shock patients without extreme endotoxemia: a post hoc analysis of the EUPHRATES trial
.
Intensive Care Med
.
2018
;
44
:
2205
12
.
12.
Snow
T
,
Littlewood
S
,
Corredor
C
,
Singer
M
,
Arulkumuran
N
.
Effect of extracorporeal blood purification on mortality in sepsis: a meta-analysis and trial sequential analysis
.
Blood Purif
.
2021
;
50
(
4–5
):
462
72
.
13.
Malard
B
,
Lambert
C
,
Kellum
JA
.
In vitro comparison of the adsorption of inflammatory mediators by blood purification devices
.
Intensive Care Med Exp
.
2018
;
6
:
12
. .
14.
Singhan
W
,
Vadcharavivad
S
,
Areepium
N
,
Wittayalertpanya
S
,
Chaijamorn
W
,
Srisawat
N
.
The effect of direct hemoperfusion with polymyxin B immobilized cartridge on meropenem in critically ill patients requiring renal support
.
J Crit Care
.
2019
;
51
:
71
6
. .
15.
Reiter
K
,
Bordoni
V
,
Dall’Olio
G
,
Ricatti
MG
,
Soli
M
,
Ruperti
S
,
In vitro removal of therapeutic drugs with a novel adsorbent system
.
Blood Purif
.
2002
;
20
(
4
):
380
8
. .
16.
Hamers
L
,
Kox
M
,
Pickkers
P
.
Sepsis: induced immunoparalysis: mechanisms, markers and treatment options
.
Minerva Anestesiol
.
2015
;
81
(
4
):
426
39
.
17.
Yaroustovsky
M
,
Abramyan
M
,
Krotenko
N
,
Popov
D
,
Plyushch
M
,
Rogalskaya
E
.
A Pilot Study of selective lipopolysaccharide adsorption and coupled plasma filtration and adsorption in adult patients with severe sepsis
.
Blood Purif
.
2015
;
39
(
1–3
):
210
7
. .
18.
Rossetti
E
,
Guzzo
I
,
Ricci
Z
,
Bianchi
R
,
Picardo
S
.
Double extracorporeal blood purification in refractory pediatric septic shock
.
Paediatr Anaesth
.
2019
;
29
(
9
):
966
7
.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.